News

AstraZeneca has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business.
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.
AstraZeneca logo is reflected in a drop on a syringe needle in this illustration photo I was in the packed hall at Davos to hear Trump speak. The audience went from laughter to silence in seconds ...
AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines.. The ...
British drugmaker AstraZeneca said on Thursday it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.
Astrazeneca (AZN.L)said on Wednesday that a meeting between the British drugmaker and European Union representatives to discuss COVID-19 vaccine supplies would go ahead as planned on Wednesday.
AstraZeneca is scaling up releases of COVID-19 vaccine doses to the United Kingdom to the point where it expects to be providing 2 million a week by or before the middle of February, a top ...
Next-Generation, Multi-Tenant Cloud Solution Offers Enhanced Capabilities for the Complete Management of Safety Signals for Improved Benefit-Risk Decisions ArisGlobal, a leading provider of ...
A sign featuring the AstraZeneca logo stands near the company's DaVinci building at the Melbourn Science Park in Cambridge, England, on June 8, 2020. MUST CREDIT: Bloomberg photo by Jason Alden.
LONDON (MarketWatch) -- Drug company AstraZeneca AZN, AZN, +0.37% said Wednesday that its its Horizon III Phase II/III head-to-head study of Recentin with chemotherapy versus bevacizumab (Avastin ...
These adverse reactions remain, however, statistically very small compared with the 17 million people so far who have been vaccinated with the AstraZeneca vaccine in Europe and the U.K.